| OXY |
Report |
Adjusted EPS from continuing operations |
BEAT |
pred ~$0.54 vs. cons $0.50 |
MEDIUM |
| OXY |
Report |
Worldwide production |
IN-LINE |
pred ~1.402 MMboe/d vs. cons 1.405 MMboe/d |
MEDIUM |
| OXY |
Report |
Free cash flow before working capital |
BEAT |
pred ~$1.45B vs. cons $1.38B |
MEDIUM |
| OXY |
Guide |
FY2026 worldwide production |
UNCHANGED |
guide ~1.440 MMboe/d vs. cons 1.440 MMboe/d (FY2026) |
HIGH |
| OXY |
Guide |
FY2026 capital expenditures |
UNCHANGED |
guide ~$5.70B vs. cons $5.70B (FY2026) |
HIGH |
| OXY |
Guide |
FY2026 midstream and marketing adjusted pre-tax income |
BETTER |
guide ~$1.25B vs. cons $1.18B (FY2026) |
MEDIUM |
| OXY |
Guide |
Principal debt at quarter-end / debt-reduction outlook |
BETTER |
guide ~$11.9B vs. cons $12.3B (2Q26) |
MEDIUM |
| OXY |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.4% |
— |
MEDIUM |
| OXY |
Return |
5-day cumulative residual |
+1.0% (FADE) |
A modest EPS/FCF beat and stronger ~$1.25B midstream outlook versus ~$1.18B should support the initial move, but unchanged ~$5.70B capex and ~1.440 MMboe/d production guidance leave limited out-period estimate upside; investors will also discount 3Q oil-price upside because 100 Mbbl/d collars cap WTI above roughly $76/bbl. |
MEDIUM |